Academia

Latest News

June 14th 2019

Understanding Price Growth in the Market for Targeted Oncology Therapies

By Jesse Sussell, PhD, Jacqueline Vanderpuye-Orgle, PhD, Diana Vania, MSc

The prices of targeted oncology therapies have grown substantially, but revenues have not. This is due in part to large declines in per-drug patient counts.

May 6th 2019

Beyond Satisfaction Scores: Exploring Emotionally Adverse Patient Experiences

By Laura M. Holdsworth, PhD, Dani L. Zionts, MScPH, Karen Marie De Sola-Smith, PhD

April 10th 2019

Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms

By Nick Ladziak, PharmD, BCACP, CDE, Nicole Paolini Albanese, PharmD, BCACP, CDE

October 1st 2013

Rhetoric Versus Reality: Promise of 'Patient-Centered' Focus in Health Reform Missing in Endocrinology Training, Compensation

By An Interview with George Grunberger, MD, FACP, FACE

Academia

Latest News

Trending on AJMC

Bringing CAR T-Cell Therapy Into Community Cancer Centers

The True Cost of Running a Community CAR T-Cell Program

Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

FDA Approves First Disease-Modifying Treatment for AxD